BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mastropasqua F, Marzano F, Valletti A, Aiello I, Di Tullio G, Morgano A, Liuni S, Ranieri E, Guerrini L, Gasparre G, Sbisà E, Pesole G, Moschetta A, Caratozzolo MF, Tullo A. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours. Mol Cancer 2017;16:67. [PMID: 28327152 DOI: 10.1186/s12943-017-0634-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Bhaduri U, Merla G. Rise of TRIM8: A Molecule of Duality. Mol Ther Nucleic Acids 2020;22:434-44. [PMID: 33230447 DOI: 10.1016/j.omtn.2020.08.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Venuto S, Monteonofrio L, Cozzolino F, Monti M, Appolloni I, Mazza T, Canetti D, Giambra V, Panelli P, Fusco C, Squeo GM, Croce AI, Pucci P, Malatesta P, Soddu S, Merla G, Micale L. TRIM8 interacts with KIF11 and KIFC1 and controls bipolar spindle formation and chromosomal stability. Cancer Letters 2020;473:98-106. [DOI: 10.1016/j.canlet.2019.12.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Valletti A, Marzano F, Pesole G, Sbisà E, Tullo A. Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer? Int J Mol Sci 2019;20:E1776. [PMID: 30974870 DOI: 10.3390/ijms20071776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
4 Marzano F, Caratozzolo MF, Pesole G, Sbisà E, Tullo A. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines 2021;9:241. [PMID: 33673719 DOI: 10.3390/biomedicines9030241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li L, He Y, He XJ, Bi MR, Qi YH, Zhu WW. Down-regulation of long noncoding RNA LINC00472 alleviates sepsis-induced acute hepatic injury by regulating miR-373-3p/TRIM8 axis. Exp Mol Pathol 2020;117:104562. [PMID: 33129786 DOI: 10.1016/j.yexmp.2020.104562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Norollahi SE, Foumani MG, Pishkhan MK, Shafaghi A, Alipour M, Jamkhaneh VB, Marghoob MN, Vahidi S. DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer. Oman Med J 2021;36:e315. [PMID: 34804598 DOI: 10.5001/omj.2020.93] [Reference Citation Analysis]
7 Zhang BH, Liu H, Yuan Y, Weng XD, Du Y, Chen H, Chen ZY, Wang L, Liu XH. Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K/Akt Signal Pathway. Drug Des Devel Ther 2021;15:4973-83. [PMID: 34916780 DOI: 10.2147/DDDT.S333372] [Reference Citation Analysis]
8 Miao LJ, Yan S, Zhuang QF, Mao QY, Xue D, He XZ, Chen JP. miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer. Onco Targets Ther 2019;12:3595-607. [PMID: 31190862 DOI: 10.2147/OTT.S184674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang Y, Wang S, Lai Q, Fang Y, Wu C, Liu Y, Li Q, Wang X, Gu C, Chen J, Cai J, Li A, Liu S. Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGF-β1 positive feedback loop. Cancer Lett 2020;491:22-35. [PMID: 32730779 DOI: 10.1016/j.canlet.2020.07.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ma YS, Wang XF, Yu F, Wu TM, Liu JB, Zhang YJ, Xia Q, Jiang ZY, Lin QL, Fu D. Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency. Signal Transduct Target Ther 2020;5:30. [PMID: 32296042 DOI: 10.1038/s41392-020-0143-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Bai X, Zhang YL, Liu LN. Inhibition of TRIM8 restrains ischaemia-reperfusion-mediated cerebral injury by regulation of NF-κB activation associated inflammation and apoptosis. Exp Cell Res 2020;388:111818. [PMID: 31917201 DOI: 10.1016/j.yexcr.2020.111818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
12 Crudele F, Bianchi N, Astolfi A, Grassilli S, Brugnoli F, Terrazzan A, Bertagnolo V, Negrini M, Frassoldati A, Volinia S. The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma. Cancers (Basel) 2021;13:4355. [PMID: 34503164 DOI: 10.3390/cancers13174355] [Reference Citation Analysis]
13 Eberhardt W, Haeussler K, Nasrullah U, Pfeilschifter J. Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma. Int J Mol Sci 2020;21:E7532. [PMID: 33066016 DOI: 10.3390/ijms21207532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lu S, Ding X, Wang Y, Hu X, Sun T, Wei M, Wang X, Wu H. The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer. Front Cell Dev Biol 2021;9:772542. [PMID: 34938735 DOI: 10.3389/fcell.2021.772542] [Reference Citation Analysis]
15 Gao S, Wang Z. Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma. J Healthc Eng 2021;2021:3533608. [PMID: 34221297 DOI: 10.1155/2021/3533608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ren T, Hou J, Liu C, Shan F, Xiong X, Qin A, Chen J, Ren W. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells. Biomedicine & Pharmacotherapy 2019;117:109171. [DOI: 10.1016/j.biopha.2019.109171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
17 Farooqi AA, Tabassum S, Ahmad A. MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. Int J Mol Sci 2017;18:E2089. [PMID: 29036883 DOI: 10.3390/ijms18102089] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
18 Caratozzolo MF, Marzano F, Mastropasqua F, Sbisà E, Tullo A. TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role. Genes (Basel) 2017;8:E354. [PMID: 29182544 DOI: 10.3390/genes8120354] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
19 Joosten SC, Smits KM, Aarts MJ, Melotte V, Koch A, Tjan-heijnen VC, van Engeland M. Epigenetics in renal cell cancer: mechanisms and clinical applications. Nat Rev Urol 2018;15:430-51. [DOI: 10.1038/s41585-018-0023-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
20 Zhao W, Zhang X, Chen Y, Shao Y, Feng Y. Downregulation of TRIM8 protects neurons from oxygen–glucose deprivation/re-oxygenation-induced injury through reinforcement of the AMPK/Nrf2/ARE antioxidant signaling pathway. Brain Research 2020;1728:146590. [DOI: 10.1016/j.brainres.2019.146590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Esposito JE, De Iuliis V, Avolio F, Liberatoscioli E, Pulcini R, Di Francesco S, Pennelli A, Martinotti S, Toniato E. Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis. Cancers 2022;14:2309. [DOI: 10.3390/cancers14092309] [Reference Citation Analysis]
22 Caratozzolo MF, Marzano F, Abbrescia DI, Mastropasqua F, Petruzzella V, Calabrò V, Pesole G, Sbisà E, Guerrini L, Tullo A. TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background. Front Oncol 2019;9:1154. [PMID: 31781486 DOI: 10.3389/fonc.2019.01154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Zhuang M, Zhao S, Jiang Z, Wang S, Sun P, Quan J, Yan D, Wang X. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine 2019;41:286-98. [PMID: 30797712 DOI: 10.1016/j.ebiom.2018.12.049] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 15.7] [Reference Citation Analysis]
24 Zhang X, Feng Y, Li J, Zheng L, Shao Y, Zhu F, Sun X. MicroRNA-665-3p attenuates oxygen-glucose deprivation-evoked microglial cell apoptosis and inflammatory response by inhibiting NF-κB signaling via targeting TRIM8. Int Immunopharmacol 2020;85:106650. [PMID: 32512270 DOI: 10.1016/j.intimp.2020.106650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Xiaoli L, Wujun Z, Jing L. Blocking of tripartite motif 8 protects against lipopolysaccharide (LPS)-induced acute lung injury by regulating AMPKα activity. Biochemical and Biophysical Research Communications 2019;508:701-8. [DOI: 10.1016/j.bbrc.2018.11.072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Tao Q, Tianyu W, Jiangqiao Z, Zhongbao C, Xiaoxiong M, Long Z, Jilin Z. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways. Int J Biol Sci 2019;15:1618-29. [PMID: 31360105 DOI: 10.7150/ijbs.33323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
27 Elshimali YI, Wu Y, Khaddour H, Wu Y, Gradinaru D, Sukhija H, Chung SS, Vadgama JV. Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 2018;1:107. [PMID: 29932172 DOI: 10.31021/jcro.20181107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Liu J, Zhang C, Wang X, Hu W, Feng Z. Tumor suppressor p53 cross-talks with TRIM family proteins. Genes Dis 2021;8:463-74. [PMID: 34179310 DOI: 10.1016/j.gendis.2020.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zhao G, Liu C, Wen X, Luan G, Xie L, Guo X. The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics. Pharmacol Ther 2021;227:107881. [PMID: 33930453 DOI: 10.1016/j.pharmthera.2021.107881] [Reference Citation Analysis]
30 Chen TJ, Zheng Q, Gao F, Yang T, Ren H, Li Y, Chen MW. MicroRNA-665 facilitates cell proliferation and represses apoptosis through modulating Wnt5a/β-Catenin and Caspase-3 signaling pathways by targeting TRIM8 in LUSC. Cancer Cell Int 2021;21:215. [PMID: 33858426 DOI: 10.1186/s12935-021-01913-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Yang C, Dou R, Yin T, Ding J. MiRNA-106b-5p in human cancers: diverse functions and promising biomarker. Biomed Pharmacother 2020;127:110211. [PMID: 32422566 DOI: 10.1016/j.biopha.2020.110211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
32 Wang Y, Chen L, Ju L, Qian K, Wang X, Xiao Y, Wang G. Epigenetic signature predicts overall survival clear cell renal cell carcinoma. Cancer Cell Int 2020;20:564. [PMID: 33292239 DOI: 10.1186/s12935-020-01640-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Mehlich D, Garbicz F, Włodarski PK. The emerging roles of the polycistronic miR-106b∼25 cluster in cancer - A comprehensive review. Biomed Pharmacother 2018;107:1183-95. [PMID: 30257332 DOI: 10.1016/j.biopha.2018.08.097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
34 Ma YS, Wang XF, Zhang YJ, Luo P, Long HD, Li L, Yang HQ, Xie RT, Jia CY, Lu GX, Chang ZY, Zhang JJ, Xue SB, Lv ZW, Yu F, Xia Q, Fu D. Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency. Mol Ther Oncolytics 2020;16:147-57. [PMID: 32055678 DOI: 10.1016/j.omto.2019.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
35 Zheng D, Zhang Y, Xia Y, Cheng F. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration. Front Oncol 2022;12:840410. [DOI: 10.3389/fonc.2022.840410] [Reference Citation Analysis]
36 Marzano F, Guerrini L, Pesole G, Sbisà E, Tullo A. Emerging Roles of TRIM8 in Health and Disease. Cells 2021;10:561. [PMID: 33807506 DOI: 10.3390/cells10030561] [Reference Citation Analysis]
37 Dang X, He B, Ning Q, Liu Y, Chang Y, Chen M. Suppression of TRIM8 by microRNA-182-5p restricts tumor necrosis factor-α-induced proliferation and migration of airway smooth muscle cells through inactivation of NF-Κb. Int Immunopharmacol 2020;83:106475. [PMID: 32283508 DOI: 10.1016/j.intimp.2020.106475] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]